|
LSG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.382800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.359200E-01 |
| Normal-vs-Stage2 |
6.740000E-01 |
| Normal-vs-Stage3 |
7.350400E-01 |
| Normal-vs-Stage4 |
1.177040E-01 |
| Stage1-vs-Stage2 |
9.570600E-01 |
| Stage1-vs-Stage3 |
8.916000E-01 |
| Stage1-vs-Stage4 |
5.108000E-01 |
| Stage2-vs-Stage3 |
8.905600E-01 |
| Stage2-vs-Stage4 |
6.022200E-01 |
| Stage3-vs-Stage4 |
4.696200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.985600E-01 |
| Normal-vs-AfricanAmerican |
2.655600E-01 |
| Normal-vs-Asian |
9.908800E-01 |
| Caucasian-vs-AfricanAmerican |
1.543390E-01 |
| Caucasian-vs-Asian |
9.410400E-01 |
| AfricanAmerican-vs-Asian |
6.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.274200E-01 |
| Normal-vs-Female |
4.586000E-01 |
| Male-vs-Female |
3.693400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.193200E-01 |
| Normal-vs-Extreme_Weight |
5.561600E-01 |
| Normal-vs-Obese |
9.364000E-01 |
| Normal-vs-Extreme_Obese |
7.597800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.808000E-01 |
| Normal_Weight-vs-Obese |
3.000800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.916200E-01 |
| Extreme_Weight-vs-Obese |
6.693600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.117600E-01 |
| Obese-vs-Extreme_Obese |
7.510600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.462600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.143200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.099200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.379800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.878400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.563600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.109600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.017190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.183900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.638000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.717560E-01 |
| Normal-VS-Type2 PRCC |
1.250840E-01 |
| Normal-VS-KIRP CIMP |
2.407800E-01 |
| Normal-VS-Unclassified PRCC |
9.402600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.563000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.901030E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.326000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.487200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.610800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.139200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.934000E-02 |
| Normal-vs-N1 |
6.128200E-01 |
| Normal-vs-N2 |
8.743400E-01 |
| N0-vs-N1 |
3.205400E-01 |
| N0-vs-N2 |
8.764200E-01 |
| N1-vs-N2 |
9.493000E-01 |
|
|
